Experimental Drug Significantly Slows Alzheimer’s: Study
May 4, 2023 – The investigational drug donanemab significantly slowed the decline of Alzheimer’s patients’ ability to think clearly and go about daily tasks in a large study of adults with early signs of the disease, according to early results.Donanemab – which is made by Eli Lily and targets amyloid plaques, a hallmark of Alzheimer’s… […]